The second annual U.S.-Taiwan Liver Health Forum, held November 15, 2019 at the Shangri-La’s Far Eastern Plaza Hotel, was a collaboration between AmCham Taipei and the American Institute in Taiwan (AIT) as part of its [email protected] campaign. The campaign’s theme for November was Innovation and Entrepreneurship Month, a fitting background for the forum, where a…

Republic of China Vice President Chen Chien-jen, an epidemiologist with a background in researching hepatitis B, was the keynote speaker at the Taiwan Liver Health Forum sponsored by AmCham Taipei together with the American Institute in Taiwan (AIT) and the Ministry of Health and Welfare (MOHW). The event, held at the Howard-Plaza Hotel on October…

Having implemented a Hepatitis B (HBC) vaccination program for newborns in 1986, Taiwan was once a pioneer in vaccination efforts.  However, Taiwan’s exclusion from participation in the World Health Organization (WHO), a tight budget, and a lack of coordination between immunization policy and healthy insurance policy have taken their toll. As a result, the development…

Despite Taiwan’s success in treating hepatitis, the prevalence of liver illnesses continues to rise. Taiwan has made great strides treating liver disease, especially the inflammatory condition hepatitis, which is usually caused by viral infections but may also result from alcohol or drug abuse or autoimmune diseases. If left untreated, hepatitis may permanently damage the liver,…